Repatha: Package Insert - Drugs.com
WEBFeb 7, 2024 · Repatha package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
WEBREPATHA is a clear to opalescent, colorless to pale yellow solution available as follows: • Injection: 140 mg/mL solution in a single-dose prefilled syringe • Injection: 140 mg/mL solution in a...
WEBREPATHA is an injectable prescription medicine used: in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of heart surgery.
WEBREPATHA is indicated as an adjunct to diet and other LDL-lowering therapies (eg, statins, ezetimibe, LDL apheresis) in adult patients and adolescent patients aged 12 years and over with homozygous familial hypercholesterolemia …
WEBREPATHA is a PCSK9 (proprotein convertase subtilisin kexin type 9) inhibitor antibody indicated: . to reduce the risk of myocardial infarction, stroke, and coronary revascularization in adults with established cardiovascular disease. (1.1)
WEBThe safety and efficacy of REPATHA in patients with severe hepatic impairment has not been studied. REPATHA should be used with caution in patients with severe hepatic impairment (Childs-Pugh, Class C). Renal Impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. There is
WEBKeep the Repatha prefilled syringe in the refrigerator between 36°F to 46°F (2°C to 8°C). If removed from the refrigerator, the Repatha prefilled syringe should be kept at room temperature at 68°F to 77°F (20°C to 25°C) in the original …
- [PDF]
PrRepatha - Amgen
WEBDosage Forms, Strengths, Composition and Packaging . REPATHA is provided as: • One mL solution (140 mg/mL evolocumab) in a single use prefilled autoinjector with type 1 glass syringe and stainless steel needle (140 mg/mL AI); supplied as …
WEBREPATHA is a PCSK9 (proprotein convertase subtilisin kexin type 9) inhibitor indicated: in adults with established cardiovascular disease (CVD) to reduce the risk of myocardial infarction,...
WEBPackaging Content (concentration) Pack size EU/1/15/1016/001 Repatha 140 mg Solution for injection Subcutaneous use Pre-filled syringe (glass) ... EU/1/15/1016/007 Repatha 420 mg Solution for injection Subcutaneous use Cartridge (plastic) 3.5 mL (120 mg/mL) 3 (3 x 1) cartridges + 3 (3 x 1) automated mini-dosers (multipack)
- Some results have been removed